Aurobindo Pharma Ltd.
|
Cash Flow
|
|
You can view the
Cash Flow
for the last 5 years.
Market Cap. (Rs.)
|
67479.62 Cr.
|
P/BV
|
2.51
|
Book Value (Rs.)
|
458.07
|
52 Week High/Low (Rs.)
|
1177/581
|
FV/ML
|
1/1
|
P/E(X)
|
35.01
|
Bookclosure
|
20/02/2024
|
EPS (Rs.)
|
32.90
|
Div Yield (%)
|
0.26
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | 2612.50 | 3372.74 | 7343.59 | 3743.04 | 3091.35 |
| | | | | |
Net CashFlow From Operating Activities | 2386.75 | 5016.48 | 3328.92 | 4381.28 | 1650.97 |
Net Cash Used In Investing Activities | -3977.75 | -3211.56 | 598.69 | -1567.64 | -2902.59 |
Net Cash Used From Financing Activities | 1814.41 | -2969.27 | -1364.81 | -1947.18 | 1919.06 |
Foreign Exchange Gains / Losses | -0.06 | 0.20 | -2.12 | 4.78 | -1.80 |
Adjustments On Amalgamation / Merger / Demerger And Others | 6.41 | -3.25 | 22.41 | 0.00 | 0.00 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | 229.76 | -1167.40 | 2583.09 | 871.24 | 665.64 |
Cash And Cash Equivalents Begin of Year | 4162.51 | 5329.91 | 2746.82 | 1875.58 | 1209.94 |
Cash And Cash Equivalents End Of Year | 4392.27 | 4162.51 | 5329.91 | 2746.82 | 1875.58 |